Average Co-Inventor Count = 4.33
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Rhizen Pharmaceuticals Sa (13 from 51 patents)
2. Incozen Therapeutics Pvt. Ltd. (1 from 7 patents)
3. Rhizen Pharmaceuticals Ag (5 patents)
4. Icozen Therapeutics Pvt. Ltd. (0 patent)
13 patents:
1. 10668051 - Modulators of calcium release-activated calcium channel
2. 10611759 - Glutaminase inhibitors
3. 10246450 - Modulators of calcium release-activated calcium channel
4. 10174034 - Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer
5. 9944631 - Modulators of calcium release-activated calcium channel
6. 9777018 - Compounds as modulators of GPR-119
7. 9758474 - Immunomodulator and anti-inflammatory compounds
8. 9758514 - Modulators of calcium release-activated calcium channel
9. 9181214 - Bicyclic compounds as modulators of GPR-119
10. 8993612 - Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer
11. 8921364 - Modulators of calcium release-activated calcium channel
12. 8686048 - Immunomodulator and anti-inflammatory compounds
13. 8377970 - Modulators of calcium release-activated calcium channel